His main research concerns Cancer research, Cancer, Endometrial cancer, Internal medicine and Pathology. His Cancer research research is multidisciplinary, incorporating perspectives in Mutation, Carcinogenesis, microRNA and PI3K/AKT/mTOR pathway, PTEN. In the field of Cancer, his study on Lynch syndrome overlaps with subjects such as Context.
The concepts of his Endometrial cancer study are interwoven with issues in Hysterectomy, Gynecology and Carcinoma. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology, Oncology and Annexin. His biological study deals with issues like Colorectal cancer, which deal with fields such as Microsatellite instability.
Russell Broaddus focuses on Internal medicine, Cancer research, Endometrial cancer, Oncology and Cancer. In his study, which falls under the umbrella issue of Internal medicine, Signal transduction is strongly linked to Endocrinology. His Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Mutation, Pathology and PI3K/AKT/mTOR pathway, PTEN.
His biological study spans a wide range of topics, including Lynch syndrome, Progesterone receptor, Carcinoma, Gynecology and Endometrium. His Lynch syndrome research incorporates elements of Germline mutation, MSH6, MLH1, Microsatellite instability and MSH2. Russell Broaddus combines subjects such as Bioinformatics, Serous fluid, KRAS, Ovarian cancer and Targeted therapy with his study of Oncology.
His scientific interests lie mostly in Internal medicine, Oncology, Cancer research, Endometrial cancer and Pathology. His studies deal with areas such as Gastroenterology and Microsatellite instability as well as Internal medicine. The Oncology study combines topics in areas such as Cancer, Targeted therapy, KRAS and Clinical trial.
His Cancer research study incorporates themes from Immune checkpoint, Carcinogenesis, Mutation, Receptor and PTEN. His Endometrial cancer research also works with subjects such as
Russell Broaddus spends much of his time researching Cancer research, Internal medicine, Cancer, Pathology and Microsatellite instability. He has included themes like Immune checkpoint, Oncogene, Transcription factor, microRNA and PTEN in his Cancer research study. His PTEN research is multidisciplinary, relying on both KRAS, Lymphatic system, Carcinoma, Carcinosarcoma and Epigenetics.
The study incorporates disciplines such as Gastroenterology and Oncology in addition to Internal medicine. His Cancer research integrates issues from Gerontology, Family medicine and Obstetrics and gynaecology. His research in Microsatellite instability intersects with topics in Incidence and Lynch syndrome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Integrated genomic characterization of endometrial carcinoma
Gad Getz;Stacey B. Gabriel;Kristian Cibulskis;Eric Lander.
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Regulation of inflammatory responses by IL-17F.
Xuexian O. Yang;Seon Hee Chang;Heon Park;Roza Nurieva.
Journal of Experimental Medicine (2008)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
Victor Abkevich;Kirsten Timms;Bryan T. Hennessy;Jennifer Potter.
British Journal of Cancer (2012)
High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
Lydia W.T. Cheung;Bryan T. Hennessy;Bryan T. Hennessy;Jie Li;Shuangxing Yu.
Cancer Discovery (2011)
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer
Da Yang;Yan Sun;Yan Sun;Limei Hu;Hong Zheng;Hong Zheng.
Cancer Cell (2013)
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Karen H. Lu;Mai Dinh;Wendy Kohlmann;Patrice Watson.
Obstetrics & Gynecology (2005)
Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer
Bryan T.J. Hennessy;Kirsten M. Timms;Mark S. Carey;Alexander Gutin.
Journal of Clinical Oncology (2010)
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.
Brian M Slomovitz;Thomas W Burke;Patricia J Eifel;Lois M Ramondetta.
Gynecologic Oncology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: